Abiraterone Mylan Europeiska unionen - finska - EMA (European Medicines Agency)

abiraterone mylan

mylan ireland limited - abirateroniasetaatti - prostatiset kasvaimet - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Locametz Europeiska unionen - finska - EMA (European Medicines Agency)

locametz

novartis europharm limited  - gozetotide - radionuklidien kuvantaminen - diagnostiset radiofarmaseuttiset valmisteet - tämä lääkevalmiste on tarkoitettu vain diagnostiseen käyttöön. locametz, after radiolabelling with gallium 68, is indicated for the detection of prostate specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high risk pca prior to primary curative therapy,suspected pca recurrence in patients with increasing levels of serum prostate specific antigen (psa) after primary curative therapy,identification of patients with psma positive progressive metastatic castration resistant prostate cancer (mcrpc) for whom psma targeted therapy is indicated (see section 4.

Upstaza Europeiska unionen - finska - EMA (European Medicines Agency)

upstaza

ptc therapeutics international limited - eladocagene exuparvovec - aminohappoaineenvaihdunta, synnynnäiset virheet - enzymes, other alimentary tract and metabolism products - upstaza is indicated for the treatment of patients aged 18 months and older with a clinical, molecular, and genetically confirmed diagnosis of aromatic l amino acid decarboxylase (aadc) deficiency with a severe phenotype (see section 5.

OLICLINOMEL N4-550  infuusioneste, emulsio Finland - finska - Fimea (Suomen lääkevirasto)

oliclinomel n4-550 infuusioneste, emulsio

baxter oy - tyrosinum,glucosum monohydricum,lysini hydrochloridum,histidinum,methioninum,valinum,leucinum,phenylalaninum,oleum olivae,acidum aminoaceticum,threoninum,isoleucinum,prolinum,soiae oleum fractionatum,alaninum,serinum,tryptophanum,argininum - infuusioneste, emulsio - yhdistelmävalmisteet

OLICLINOMEL N4-550 E  infuusioneste, emulsio Finland - finska - Fimea (Suomen lääkevirasto)

oliclinomel n4-550 e infuusioneste, emulsio

baxter oy - phenylalaninum,natrii acetas trihydricus,acidum aminoaceticum,tryptophanum,prolinum,argininum,calcii chloridum dihydricum,isoleucinum,serinum,threoninum,histidinum,tyrosinum,natrii glycerophosphas pentahydricu,methioninum,magnesii chloridum hexahydricum,soiae oleum fractionatum,glucosum monohydricum,kalii chloridum,alaninum,leucinum,oleum olivae,valinum,lysini hydrochloridum - infuusioneste, emulsio - yhdistelmävalmisteet

OLICLINOMEL N5-800  infuusioneste, emulsio Finland - finska - Fimea (Suomen lääkevirasto)

oliclinomel n5-800 infuusioneste, emulsio

baxter oy - leucinum,glucosum monohydricum,valinum,tryptophanum,serinum,acidum aminoaceticum,threoninum,lysini hydrochloridum,oleum olivae,prolinum,argininum,alaninum,isoleucinum,phenylalaninum,methioninum,tyrosinum,histidinum - infuusioneste, emulsio - yhdistelmävalmisteet

OLICLINOMEL N5-800 E  infuusioneste, emulsio Finland - finska - Fimea (Suomen lääkevirasto)

oliclinomel n5-800 e infuusioneste, emulsio

baxter oy - valinum,magnesii chloridum hexahydricum,calcii chloridum dihydricum,argininum,oleum olivae,methioninum,lysini hydrochloridum,prolinum,soiae oleum fractionatum,kalii chloridum,acidum aminoaceticum,tryptophanum,glucosum monohydricum,histidinum,leucinum,natrii glycerophosphas pentahydricu,natrii acetas trihydricus,alaninum,tyrosinum,serinum,threoninum,isoleucinum,phenylalaninum - infuusioneste, emulsio - yhdistelmävalmisteet

OLICLINOMEL N6-900  infuusioneste, emulsio Finland - finska - Fimea (Suomen lääkevirasto)

oliclinomel n6-900 infuusioneste, emulsio

baxter oy - threoninum,leucinum,serinum,glucosum monohydricum,tyrosinum,prolinum,argininum,histidinum,lysini hydrochloridum,soiae oleum fractionatum,valinum,oleum olivae,isoleucinum,acidum aminoaceticum,alaninum,tryptophanum,phenylalaninum,methioninum - infuusioneste, emulsio - yhdistelmävalmisteet

OLICLINOMEL N6-900 E  infuusioneste, emulsio Finland - finska - Fimea (Suomen lääkevirasto)

oliclinomel n6-900 e infuusioneste, emulsio

baxter oy - calcii chloridum dihydricum,tyrosinum,natrii glycerophosphas pentahydricu,soiae oleum fractionatum,argininum,histidinum,methioninum,serinum,valinum,magnesii chloridum hexahydricum,alaninum,leucinum,kalii chloridum,prolinum,natrii acetas trihydricus,oleum olivae,threoninum,isoleucinum,acidum aminoaceticum,glucosum monohydricum,tryptophanum,phenylalaninum,lysini hydrochloridum - infuusioneste, emulsio - yhdistelmävalmisteet

OLICLINOMEL N7-1000  infuusioneste, emulsio Finland - finska - Fimea (Suomen lääkevirasto)

oliclinomel n7-1000 infuusioneste, emulsio

baxter oy - leucinum,threoninum,valinum,alaninum,tyrosinum,glucosum monohydricum,phenylalaninum,tryptophanum,prolinum,histidinum,oleum olivae,lysini hydrochloridum,argininum,isoleucinum,soiae oleum fractionatum,acidum aminoaceticum,methioninum,serinum - infuusioneste, emulsio - yhdistelmävalmisteet